Search Results 2691-2700 of 17686 for rheumatoid arthritis

  1. Publications - Harry H. Yoon, M.D. - Mayo Clinic

    Vascular endothelial growth factor, FLT-1, and FLK-1 analysis in a pancreatic cancer tissue microarray. Cancer. 2006 Apr 15; 106(8):1677-84. View PubMed ...

  2. Myelodysplastic Syndromes Clinical Trials - Mayo Clinic Research

    The primary objective of this study is to determine the safety and tolerability of utilizing the insulin-like growth factor-1-methotrexate conjugate, 765IGF ...

  3. Resorcinol and sulfur (topical route) - Mayo Clinic

    This medicine is available without a prescription. This product is available in the following dosage forms: Lotion; Cream. Back to top ...

  4. Find clinical trials - Oncology (Medical)

    The human epidermal growth factor receptor 2 (HER2) regulates cell growth and survival. Approximately 15-20% of all breast cancers are HER2-positive, which ...

  5. Sarcoma - Doctors and departments - Mayo Clinic

    ritis, Arthritis, Periprosthetic fracture, Sarcoma, Bone metastasis, Avascular necrosis, Infected total hip replacement, Infected total knee replacement ...

  6. An Extension Study of Oral Ozanimod for Moderately-to-Severely Active Crohn's Disease - Mayo Clinic

    chronic non-steroidal anti-inflammatory drug (NSAID) use (note: occasional use of NSAIDs and acetaminophen [e.g., headache, arthritis, myalgias, or ...

  7. A Study to Compare Ultrasound Guided – Incisionless Thread Carpal Tunnel Release Versus Standard Mini-Open Carpal Tunnel Release for the Treatment of Carpal Tunnel Syndrome - Mayo Clinic

    Hand arthritis (rheumatologic or osteoarthritis). Pregnancy. Electromyographic evidence of any condition other than CTS affecting the hand. Workman's ...

  8. Mayo Clinic Q and A: Chronic Hives Come and Go With No Clear Pattern

    Up to 90 percent of cases remain unexplained — no external factor or contributing disease can be pinpointed as the cause. People with chronic hives often ...

  9. Obinutuzumab With or Without PI3K-delta Inhibitor TGR-1202, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma - Mayo Clinic

    ... factor X inhibitors or Warfarin if randomized to lenalidomide; patients must also be willing to receive pneumocystis jirovecii prophylaxis with ...

  10. A Study of Response, Survival, Safety, and Tolerability of Lenvatinib for the Treatment of Anaplastic Thyroid Cancer - Mayo Clinic

    ... factor or transfusion); Platelet count ≥ 100 x 10^9/L. Adequate blood coagulation function as evidenced by an International Normalized Ratio (INR) ≤ 1.5 ...